Bone scan test for kidney function in cancer patients
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether a bone scan can check kidney function in cancer patients who have received kidney-damaging chemotherapy like Cisplatin. It may help doctors monitor kidneys without extra blood tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You have a history of cancer treated with Cisplatin or similar chemotherapy that can harm kidneys.
- You are scheduled for a bone scan as part of your cancer checkup.
- You have recent kidney function test results (serum creatinine) to calculate your eGFR.
- You do not have known kidney failure or other major kidney problems.
- You are not pregnant and have no medical reasons that prevent a bone scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special PET scan (using a radioactive tracer called rubidium-82) can help doctors better understand how aggressive a kidney cancer is before surgery. If you have a medium-sized kidney tumor that looks like clear cell cancer and you are scheduled for surgery, you may be able to join.
This Phase 1 study tests whether a special PET/CT scan drug ([18F]PT2385) can help doctors see kidney cancer and related tumors. It may help guide diagnosis and treatment decisions, especially in people planning surgery or starting belzutifan.
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
This study uses a CT scan to estimate how strong a cancer-affected bone area is, helping doctors evaluate fracture risk and bone management. It is aimed at adults with bone lesions from several common cancer types.
This trial uses a special PET scan to detect if kidney cancer remains or returns after treatment. It may help find cancer that's hard to see on other scans.
This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.
Hear when a new Cancer Patients Treated by Nephrotoxic Chemotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.